Suraksha Diagnostic Limited (BOM:544293)
India · Delayed Price · Currency is INR 324.05
-3.80 (-1.16%)
At close: Sep 11, 2026
Suraksha Diagnostic Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 3,255 | 3,104 | 2,521 | 2,187 | 1,901 | 2,232 | |
Revenue Growth | 23.31% | 23.14% | 15.26% | 15.03% | -14.81% | 59.42% |
Cost of Revenue | 377.2 | 456.79 | 377.21 | 354.02 | 371.17 | 700.89 |
Gross Profit | 2,878 | 2,647 | 2,144 | 1,833 | 1,530 | 1,531 |
Selling, General & Admin | 548.92 | 646.57 | 510.59 | 459.7 | 481.69 | 403.37 |
Other Operating Expenses | 1,295 | 1,039 | 793.62 | 645.88 | 584.9 | 486.74 |
Operating Expenses | 2,276 | 2,105 | 1,682 | 1,437 | 1,383 | 1,174 |
Operating Income | 601.44 | 542.39 | 462 | 396.14 | 146.87 | 356.98 |
Interest Expense | -135.71 | -125.53 | -83.85 | -87.88 | -90.6 | -88.46 |
Interest & Investment Income | - | 22.54 | 32.25 | 32.2 | 25.37 | 17.17 |
Other Non Operating Income (Expenses) | 33.46 | 5.27 | 3.71 | 3.31 | 4.25 | 3.01 |
EBT Excluding Unusual Items | 499.19 | 444.65 | 414.11 | 343.77 | 85.89 | 288.7 |
Gain (Loss) on Sale of Investments | - | - | - | - | - | 0.09 |
Gain (Loss) on Sale of Assets | - | -2.93 | -2.56 | -21.45 | -24.32 | -14.15 |
Asset Writedown | -13.06 | - | - | -7.79 | - | - |
Other Unusual Items | - | 3.81 | 2.3 | - | 5.91 | 3.71 |
Pretax Income | 486.14 | 445.54 | 413.85 | 314.53 | 67.48 | 278.35 |
Income Tax Expense | 135.41 | 131.52 | 104.07 | 83.26 | 6.83 | 70.11 |
Earnings From Continuing Operations | 350.73 | 314.03 | 309.78 | 231.26 | 60.65 | 208.24 |
Minority Interest in Earnings | 7.25 | 7.85 | 8.46 | 4.99 | 4.51 | - |
Net Income | 357.98 | 321.87 | 318.24 | 236.25 | 65.16 | 208.24 |
Net Income to Common | 357.98 | 321.87 | 318.24 | 236.25 | 65.16 | 208.24 |
Net Income Growth | 7.56% | 1.14% | 34.70% | 262.57% | -68.71% | 223.60% |
Shares Outstanding (Basic) | 52 | 52 | 52 | 53 | 53 | 53 |
Shares Outstanding (Diluted) | 52 | 52 | 52 | 53 | 53 | 53 |
Shares Change | 0.44% | - | -2.29% | - | - | -0.02% |
EPS (Basic) | 6.88 | 6.18 | 6.11 | 4.43 | 1.22 | 3.91 |
EPS (Diluted) | 6.88 | 6.18 | 5.97 | 4.43 | 1.22 | 3.91 |
EPS Growth | 9.50% | 3.52% | 34.76% | 263.12% | -68.77% | 223.61% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | 144.85 | 213.35 | 150.09 | 309.29 | 385.74 |
Free Cash Flow Per Share | - | 2.78 | 4.10 | 2.82 | 5.80 | 7.24 |
Dividend Per Share | - | 0.500 | - | - | - | - |
Dividend Growth | - | - | - | - | - | - |
Gross Margin | 88.41% | 85.28% | 85.04% | 83.81% | 80.48% | 68.60% |
Operating Margin | 18.48% | 17.47% | 18.33% | 18.11% | 7.72% | 15.99% |
Profit Margin | 11.00% | 10.37% | 12.62% | 10.80% | 3.43% | 9.33% |
Free Cash Flow Margin | - | 4.67% | 8.46% | 6.86% | 16.27% | 17.28% |
EBITDA | 1,073 | 770.02 | 647.24 | 555.14 | 299.4 | 502.07 |
EBITDA Margin | 32.98% | 24.81% | 25.67% | 25.38% | 15.75% | 22.50% |
D&A For EBITDA | 471.8 | 227.63 | 185.24 | 159.01 | 152.53 | 145.09 |
EBIT | 601.44 | 542.39 | 462 | 396.14 | 146.87 | 356.98 |
EBIT Margin | 18.48% | 17.47% | 18.33% | 18.11% | 7.72% | 15.99% |
Effective Tax Rate | 27.85% | 29.52% | 25.15% | 26.47% | 10.12% | 25.19% |
Revenue as Reported | 3,288 | 3,136 | 2,559 | 2,223 | 1,937 | 2,258 |
Advertising Expenses | - | 53.54 | 40.42 | 34.01 | 44.4 | 28.22 |